Association of monoamine oxidase B alleles with age at onset in amyotrophic lateral sclerosis

Neuromuscular Disorders

Volumn 9, Issue 8, 1999, Pages 593-597

  Orru S ^a,b   Mascia, V ^c   Casula, M ^a   Giuressi, E ^a   Loizedda, A ^a   Carcassi, C ^a   Giagheddu, M ^c   Contu, L ^a  

^a Dipto Sci Mediche e Internistiche   (Italy)

^b Dipto di Biologia Sperimentale   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Age onset; Amyotrophic lateral sclerosis genetics; Chromosome X; Disease genetic association; Human; Microsatellite markers; Monoamine oxidase genetics; Polymorphisms genetics

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME B; MICROSATELLITE DNA;

ADULT; AGE; AGED; ALLELE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CONTROLLED STUDY; FEMALE; GENETIC MARKER; GENETIC POLYMORPHISM; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; X CHROMOSOME;

ADULT; AGE OF ONSET; AGED; ALLELES; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; GENE FREQUENCY; HUMANS; MALE; MIDDLE AGED; MONOAMINE OXIDASE; SEX DISTRIBUTION;

EID: 0032741787     PISSN: 09608966     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-8966(99)00052-8     Document Type: Article

References (39)

1. Weyler W., Hsu Y.P.P., Breakefield X.O. Biochemistry and genetic of monoamine oxidase. J Pharmacol Ther. 47:1990;391-417.
2. Chen Z.Y., Powell J.F., Hsu Y.P., Breakefield X.O., Craig I.W. Organization of the human monoamine oxidase genes and long-range physical mapping around them. Genomic. 14:1992;75-82.
3. Stenstrom A., Hardy J., Oreland L. Intra- and extra-dopamine-synaptosomal localization of monoamine oxidase in striatal homogenates from four species. Biochem Pharmacol. 18:1987;2931-2935.
4. Adolfsson R., Gottfries C.G., Oreland L., Wiberg A., Winbland B. Increased activity of brain and platelet monoamine oxidase in dementia of Alzheimer type. Life Sci. 27:1980;1029-1034.
5. Steventon G.B., Humfrey C., Sturman S., et al. Monoamine oxidase B and Parkinson's disease. Lancet. 1:1990;180.
6. Jossan S.S., Gilberg P.G., Gottfries C.G., Karlsson I., Oreland L. Monoamine oxidase B in brain from patients with Alzheimer's disease: A biochemical and autoradiographical study. Neuroscience. 45:1991;1-12.
7. Aquilonius S.M., Jossan S.S., Ekblom J.G., Askmark H., Gillberg P.G. Increased binding of 3H-L-deprenyl in spinal cords from patients with amyotrophic lateral sclerosis as demonstrated by autoradiography. J Neural Trans Gen Sect. 89:1992;111-122.
8. Ekblom J., Jossan S.S., Gillberg P.G., Oreland L., Aquilonius S.M. Monoamine oxidase-B; changes in amyotrophic lateral sclerosis. ALS. Neuroscience. 49:1992;763-769.
9. Jossan S.S., Ekblom J., Aquilonius S.M., Oreland L. Monoamine oxidase-B in motor cortex and spinal cord in amyotrophic lateral sclerosis studied by quantitative autoradiography. J Neural Trans. 41:1994;243-248.
10. Brunner H.G., Nelen M., Breakefield X.O., Ropers H.H., van Oost B.A. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science. 262:1993;578-580.
11. Lim L.C., Powell J., Sham P., et al. Evidence for a genetic association between alleles of monoamine oxidase A gene and bipolar affective disorder. Am J Med Genet. 60:1995;325-331.
12. Vanyukov M.M., Moss H.B., Yu L.M., Tarter R.E., Dake R. Preliminary evidence for an association of a dinucleotide repeat polymorphism at the MAO-A gene with early onset alcoholism/substance abuse. Am J Med Genet. 60:1995;122-126.
13. Hotamisligil G.S., Girmen A.S., Fink J.S., et al. Hereditary variations in monoamine oxidase as a risk factor for Parkinson's disease. Mov Disord. 9:1994;305-310.
14. Halliwell B. Oxidants and the nervous system: some fundamental questions. Acta Neurol Scand. 126:1989;23-33.
15. Kurth J.H., Kurt M.C., Poduslo S.E., Schwankhaus J.D. Association of a monoamino oxidase B allele with Parkinson's disease. Ann Neurol. 33:1993;368-372.
16. Costa P., Checkoway H., Levy D., Smith-Weller T., Franklin G.M., Swanson P.D., Costa L.G. Associations of a polymorphism in intron 13 of the monoamine oxidase B gene with Parkinson disease. Am J Med Genet. 74:(2):1997;154-156.
17. Salach J.I., Singer T.P., Castagnoli N.J.R., Trevor A. Oxidation of the neurotoxic amine MPTP by monoamine oxidase A and B and suicide inactivation of the enzymes by MPTP. Biochem Biophys Res Commun. 125:1984;831.
18. Rosen D.R., Siddique T., Patterson D., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
19. Brown R.H. Superoxide dismutase and familial amyotrophic lateral sclerosis: new insights into mechanisms and treatments. Ann Neurol. 39:1996;145-146.
20. Trotti D., Danbolt N.C., Volterra A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol Sci. 19:(8):1998;328-334.
21. Bogdanov M.B., Ramos L.E., Xu Z., Beal M.F. Evaluated 'hydroxyl radical' generation in vivo in an animal model of amyotrophic lateral sclerosis. J Neurochem. 71:(3):1998;1321-1324.
22. Spencer J.P.E., Jenner A., Aruoma O.I., et al. Intense oxidative DNA damage promoted by L-DOPA and its metabolites. Implications for neurodegenerative disease. FEBS Lett. 353:1994;246-250.
23. Takahashi H., Snow B.J., Bhatt M.H., Peppard R., Eisen A., Calne D.B. Evidence for a dopaminergic deficit in sporadic amyotrophic lateral sclerosis on positron emission scanning. Lancet. 342:1993;1016-1018.
24. Borasio G.D, Linke R., Schwarz J., et al. Dopaminergic deficit in amyotrophic lateral sclerosis assessed with [I-123] IPT single photon emission computed tomography. J Neurol Neurosurg Psychiatry. 65:(2):1998;263-265.
25. El Escorial World Federation of Neurology Criteria for the Diagnosis of Amyotrophic Lateral Sclerosis. J Neurol Sci. 124:(suppl):1994;96-107.
26. Mitsumoto H. Diagnosis and progression of ALS. Neurology. 48 (Suppl. 4):1997;S2-S8.
27. Kimura A., Sasazuki T. Tsuji K., Aizawa M., Sasazuki T. Eleventh International Histocompatibility Workshop reference protocol for the HLA-DNA typing technique. 1992;1-397 Oxford University Press, Oxford.
28. Konradi C., Ozelius L., Breakefield X.O. Highly polymorphic (GT)n repeat sequence in intron 2 of the human MAOB gene. Genomics. 12:1992;176-177.
29. Eisen A. Amyotrophic lateral sclerosis is a multifactorial disease. Muscle Nerve. 18:(7):1995;741-752.
30. Hentati A., Bejaoui K., Pericak-Vance M.A., Hentati F., Speer M.C., et al. Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-q35. Nat Genet. 7:(3):1994;425-428.
31. Giagheddu M., Puggioni G., Masala C., et al. Epidemiologic study of amyotrophic lateral sclerosis in Sardinia. Italy. Acta Neurol Scand. 68:1983;394-404.
32. Giagheddu M., Mascia V., Cannas A., et al. Amyotrophic lateral sclerosis in Sardinia. Italy, an epidemiologic study. Acta Neurol Scand. 87:1993;446-454.
33. Morrison B.M., Hof P.R., Morrison J.H. Determinants of neuronal vulnerability in neurodegenerative disease. Ann Neurol. 3(Suppl 1):1998;S32-S44.
34. Ekblom J., Jossan S.S., Bergstrom M., Oreland L., Walum E., Aquilonius S.M. Monoamine oxidase-B and astrocytes. Glia. 8:1993;122-132.
35. Frederickson R.C.A. Astroglia in Alzheimer's disease. Neurobiol Aging. 13:1992;239-253.
36. Gershon E.S., Goldin L.R., Lake C.R., Murphy D.L., Guroff J.J. Genetics of plasma dopamine-hydroxylase (DBH), erythrocyte catechol-o-methyltransferase (COMT), and platelet monoamine oxidase (MAO) in pedigrees of patients with affective disorders. Usdin E., Sourkers P., Youdin M.B.H. Enzymes and neurotransmitters in mental disease. 1980;281-299 Wiley, London.
37. Rice J., McGuffin P., Goldin L.R., Shaskan E.G., Gershon E.S. Platelet monoamine oxidase (MAO) activity; evidence for a single major locus. Am J Hum Genet. 36:1984;36-43.
38. Hotamisligil G.S., Breakefield X.O. Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet. 49:1991;383-392.
39. Grimsby J., Chen K., Wang L.J., Lan N.C., Shih J.C. Human monoamine oxidase A and B genes exhibit identical exon-intron organization. Proc Natl Acad Sci USA. 88:1991;3637-3641.